As oligo therapeutics advance toward commercial production, scalable synthesis and process control become critical. Discover practical strategies for improving efficiency, reducing risk, and accelerating scale-up in our latest eBook. Download the eBook.
Explore strategies to maximize drug product recovery during sterile filtration, minimize hold-up volume, and reduce dilution after PUPSIT to ensure higher yield, improved efficiency, and less waste.
cGMP liquid solutions streamline upstream and downstream bioprocessing. Reclaim cleanroom capacity, enhance process consistency, and reduce contamination risks from development to commercial production.
Streamline downstream bioprocess teardown with high-flow, non-spill disconnect solutions designed to resist harsh chemicals and protect closed system fluid lines.
Achieve maximum analyte recovery with bioinert column hardware. Advanced particle platforms and diverse chemistries provide superior resolution and robust performance for bioseparations.
Efficient purification requires scalable chromatography and advanced automation. See how customizable systems and precision software optimize results for peptides, proteins, and more.
Closed, aseptic flasks in three surface areas support controlled cell expansion in therapy workflows, with sterile connections that carry seed trains into larger multilayer vessels.
Discover how single-use technologies support critical fluid management workflows across bioprocessing, cell and gene therapy, and blood management, enabling efficient handling, storage, and transfer.
